Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V A Fonseca

Showing results (31-40 of 37) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 37 results.
Canadian Journal of Physiology and Pharmacology|January 15, 2009
Animal models of catheter-induced intimal hyperplasia in type 1 and type 2 diabetes and the effects of pharmacologic interventionD B McNamara, S N Murthy, A N Fonseca, et al.
Journal of Diabetes and Its Complications|July 1, 1998
Effect of troglitazone on fibrinolysis and activated coagulation in patients with non-insulin-dependent diabetes mellitusV A Fonseca, T Reynolds, D Hemphill, et al.
American Journal of Clinical Pathology|October 1, 1991
Intraplatelet serotonin, beta-thromboglobulin, and histamine concentrations and thromboxane A2 synthesis in renal diseaseM A Barradas, V A Fonseca, D S Gill, et al.
Metabolism: Clinical and Experimental|September 14, 2001
Blood S-adenosylmethionine concentrations and lymphocyte methylenetetrahydrofolate reductase activity in diabetes mellitus and diabetic nephropathyL A Poirier, A T Brown, L M Fink, et al.
Metabolism: Clinical and Experimental|September 18, 2004
Hypoglycemic potential of nateglinide versus glyburide in patients with type 2 diabetes mellitusV A Fonseca, D E Kelley, W Cefalu, et al.
Journal of Diabetes and Its Complications|July 12, 2020
COVID-19 in people living with diabetes: An international consensusA E Caballero, A Ceriello, A Misra, et al.
Diabetes, Obesity & Metabolism|August 6, 2013
Efficacy and safety of initial combination treatment with sitagliptin and pioglitazone--a factorial studyR R Henry, B Staels, V A Fonseca, et al.
Pageof 4

Showing results (31-40 of 37) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 37 results.
Canadian Journal of Physiology and Pharmacology|January 15, 2009
Animal models of catheter-induced intimal hyperplasia in type 1 and type 2 diabetes and the effects of pharmacologic interventionD B McNamara, S N Murthy, A N Fonseca, et al.
Journal of Diabetes and Its Complications|July 1, 1998
Effect of troglitazone on fibrinolysis and activated coagulation in patients with non-insulin-dependent diabetes mellitusV A Fonseca, T Reynolds, D Hemphill, et al.
American Journal of Clinical Pathology|October 1, 1991
Intraplatelet serotonin, beta-thromboglobulin, and histamine concentrations and thromboxane A2 synthesis in renal diseaseM A Barradas, V A Fonseca, D S Gill, et al.
Metabolism: Clinical and Experimental|September 14, 2001
Blood S-adenosylmethionine concentrations and lymphocyte methylenetetrahydrofolate reductase activity in diabetes mellitus and diabetic nephropathyL A Poirier, A T Brown, L M Fink, et al.
Metabolism: Clinical and Experimental|September 18, 2004
Hypoglycemic potential of nateglinide versus glyburide in patients with type 2 diabetes mellitusV A Fonseca, D E Kelley, W Cefalu, et al.
Journal of Diabetes and Its Complications|July 12, 2020
COVID-19 in people living with diabetes: An international consensusA E Caballero, A Ceriello, A Misra, et al.
Diabetes, Obesity & Metabolism|August 6, 2013
Efficacy and safety of initial combination treatment with sitagliptin and pioglitazone--a factorial studyR R Henry, B Staels, V A Fonseca, et al.
Pageof 4